Table 1.
Mean values (± standard deviation) at baseline, 6 months and 12 months of treatment.
| Baseline | 6 months | 12 months | |
|---|---|---|---|
| Fat body mass (g) | 21,130.96 (7731.12) | – | 24,051.7 (8135.73) |
| Lean body mass (g) | 59,254.28 (9092.13) | – | 59,067.17 (8092.4) |
| BMI (kg/m2) | 26.5 (4.1) | 27.1 (4.3) | 27.3 (4.1) |
| Total cholesterol (mg/dL) | 190.5 (31.3) | 194.6 (28.2) | 186.5 (32.6) |
| HDL (mg/dL) | 55.6 (16.6) | 58.1 (17.3) | 55.1 (15.1) |
| LDL (mg/dL) | 109.7 (26.9) | 108.4 (26.4) | 107.2 (26.8) |
| Triglycerides (mg/dL) | 110.0 (42.9) | 131.9 (85.9) | 119.6 (53.5) |
| Glucose (mg/dL) | 102.5 (18.2) | 105.5 (24.5) | 104.2 (21.2) |
| HbA1c (mmol/mol) | 39.5 (5.3) | 42.3 (7.3) | 43.1 (7.3) |
| FSH (UI/L) | 11.7 (11.1) | 1.4 (1.1) | 2.3 (2.6) |
| PSA (ng/mL) | 12.7 (33.6) | 0.3 (1.0) | 0.2 (0.4) |
BMI body mass index, HDL high-density lipoprotein, LDL low-density lipoprotein, HbA1c glycated hemoglobin, FSH follicle-stimulating hormone, PSA prostate specific antigen.